| Lindsey Jo Robinson, RN | |
|
500 W Fort St Bldg T122, Boise, ID 83702-4599 | |
| (208) 422-1000 | |
| (208) 422-1386 |
| Full Name | Lindsey Jo Robinson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 500 W Fort St Bldg T122, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477250157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | N-43476 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Jo Robinson, RN 4496 S Carie Way, Boise, ID 83709-5893 Ph: (208) 284-9217 | Lindsey Jo Robinson, RN 500 W Fort St Bldg T122, Boise, ID 83702-4599 Ph: (208) 422-1000 |
News Archive
BioDelivery Sciences International, Inc. today announced the issuance of United States Patent 7,579,019, which will provide additional patent exclusivity for both ONSOLIS and BDSI's BEMA drug delivery technology platform until at least 2019.
Nutrition rating systems and symbols on the fronts of food packaging would be most useful to shoppers if they highlighted four nutrients of greatest concern - calories, saturated fat, trans fat, and sodium - says a new report from the Institute of Medicine. These food components are routinely overconsumed and associated most strongly with diet-related health problems affecting many Americans, including obesity, heart disease, high blood pressure, Type 2 diabetes, and certain types of cancer.
A team of scientists from China and the USA has recently described the antiviral efficacy of a monoclonal antibody candidate targeting the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Importantly, they have observed that emerging spike mutations could not affect the potency of this antibody. The study is currently available on the bioRxiv* preprint server.
Women are 37 percent more likely to have chronic obstructive pulmonary disease (COPD) than men and now account for more than half of all deaths attributed to COPD in our nation.
Ludwig Cancer Research and the Cancer Research Institute have launched a Phase 1/2 clinical trial of combination immunotherapy for advanced ovarian cancer. The international, multicenter trial is led by George Coukos, director of the Ludwig Institute for Cancer Research, Lausanne and Brad Monk, director of Gynecologic Oncology at St. Joseph's Hospital and Medical Center.
› Verified 6 days ago
Robert Fisher, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1092 | |
Christopher M Gutierrez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Trina S Hunter, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8601 W Emerald St Ste 160, Boise, ID 83704 Phone: 208-991-4488 | |
Rebecca Cotterell, RN-BC, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1591 | |
Laura Rossow, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Alicia Curmi, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 417 S 6th St, Boise, ID 83702 Phone: 734-812-3214 | |
Kevin L Coleman, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 811 N Liberty St, Boise, ID 83704 Phone: 208-323-4522 |